Literature DB >> 22020259

Brain specific kinase-1 BRSK1/SAD-B associates with lipid rafts: modulation of kinase activity by lipid environment.

Arantza Rodríguez-Asiain1, Gerard Ruiz-Babot, Walter Romero, Roger Cubí, Tatiana Erazo, Ricardo M Biondi, Jose R Bayascas, Jose Aguilera, Nestor Gómez, Carles Gil, Enrique Claro, Jose M Lizcano.   

Abstract

Brain specific kinases 1 and 2 (BRSK1/2, also named SAD kinases) are serine-threonine kinases specifically expressed in the brain, and activated by LKB1-mediated phosphorylation of a threonine residue at their T-loop (Thr189/174 in human BRSK1/2). BRSKs are crucial for establishing neuronal polarity, and BRSK1 has also been shown to regulate neurotransmitter release presynaptically. How BRSK1 exerts this latter function is unknown, since its substrates at the synaptic terminal and the mechanisms modulating its activity remain to be described. Key regulators of neurotransmitter release, such as SNARE complex proteins, are located at membrane rafts. Therefore we initially undertook this work to check whether BRSK1 also locates at these membrane microdomains. Here we show that brain BRSK1, but not BRSK2, is palmitoylated, and provide biochemical and pharmacological evidences demonstrating that a pool of BRSK1, but not BRSK2 or LKB1, localizes at membrane lipid rafts. We also show that raft-associated BRSK1 has higher activity than BRSK1 from non-raft environment, based on a higher T-loop phosphorylation at Thr-189. Further, recombinant BRSK1 activity increased 3-fold when assayed with small multilamellar vesicles (SMV) generated with lipids extracted from synaptosomal raft fractions. A similar BRSK1-activating effect was obtained with synthetic SMV made with phosphatidylcholine, cholesterol and sphingomyelin, mixed in the same molar ratio at which these three major lipids are present in rafts. Importantly, SMV also enhanced the activity of a constitutively active BRSK1 (T189E), underpinning that interaction with lipid rafts represents a new mechanism of BRSK1 activity modulation, additional to T-loop phosphorylation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020259     DOI: 10.1016/j.bbalip.2011.10.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Slippery signaling: Palmitoylation-dependent control of neuronal kinase localization and activity.

Authors:  Audrey Montersino; Gareth M Thomas
Journal:  Mol Membr Biol       Date:  2016-05-31       Impact factor: 2.857

2.  Interaction of PDK1 with phosphoinositides is essential for neuronal differentiation but dispensable for neuronal survival.

Authors:  Tinatin Zurashvili; Lluís Cordón-Barris; Gerard Ruiz-Babot; Xiangyu Zhou; Jose M Lizcano; Nestor Gómez; Lydia Giménez-Llort; Jose R Bayascas
Journal:  Mol Cell Biol       Date:  2012-12-28       Impact factor: 4.272

3.  Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.

Authors:  Tatiana Erazo; Ana Moreno; Gerard Ruiz-Babot; Arantza Rodríguez-Asiain; Nicholas A Morrice; Josep Espadamala; Jose R Bayascas; Nestor Gómez; Jose M Lizcano
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

4.  Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.

Authors:  Anne-Lotte L F van der Kooi; Marloes van Dijk; Linda Broer; Marleen H van den Berg; Joop S E Laven; Flora E van Leeuwen; Cornelis B Lambalk; Annelies Overbeek; Jacqueline J Loonen; Helena J van der Pal; Wim J Tissing; Birgitta Versluys; Dorine Bresters; Catharina C M Beerendonk; Cécile R Ronckers; Margriet van der Heiden-van der Loo; Gertjan L Kaspers; Andrica C H de Vries; Leslie L Robison; Melissa M Hudson; Wassim Chemaitilly; Julianne Byrne; Claire Berger; Eva Clemens; Uta Dirksen; Jeanette Falck Winther; Sophie D Fosså; Desiree Grabow; Riccardo Haupt; Melanie Kaiser; Tomas Kepak; Jarmila Kruseova; Dalit Modan-Moses; Saskia M F Pluijm; Claudia Spix; Oliver Zolk; Peter Kaatsch; Jesse H Krijthe; Leontien C Kremer; Yutaka Yasui; Russell J Brooke; André G Uitterlinden; Marry M van den Heuvel-Eibrink; Eline van Dulmen-den Broeder
Journal:  Hum Reprod       Date:  2021-03-18       Impact factor: 6.918

5.  The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells.

Authors:  Pau Muñoz-Guardiola; Josefina Casas; Elisabet Megías-Roda; Sònia Solé; Héctor Perez-Montoyo; Marc Yeste-Velasco; Tatiana Erazo; Nora Diéguez-Martínez; Sergio Espinosa-Gil; Cristina Muñoz-Pinedo; Guillermo Yoldi; Jose L Abad; Miguel F Segura; Teresa Moran; Margarita Romeo; Joaquim Bosch-Barrera; Ana Oaknin; Jose Alfón; Carles Domènech; Gemma Fabriàs; Guillermo Velasco; Jose M Lizcano
Journal:  Autophagy       Date:  2020-05-25       Impact factor: 16.016

6.  Evaluating GWAS-identified SNPs for age at natural menopause among chinese women.

Authors:  Chong Shen; Ryan J Delahanty; Yu-Tang Gao; Wei Lu; Yong-Bing Xiang; Ying Zheng; Qiuyin Cai; Wei Zheng; Xiao-Ou Shu; Jirong Long
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

7.  Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.

Authors:  Xianming Deng; Jonathan M Elkins; Jinwei Zhang; Qingkai Yang; Tatiana Erazo; Nestor Gomez; Hwan Geun Choi; Jinhua Wang; Nicolas Dzamko; Jiing-Dwan Lee; Taebo Sim; NamDoo Kim; Dario R Alessi; Jose M Lizcano; Stefan Knapp; Nathanael S Gray
Journal:  Eur J Med Chem       Date:  2013-10-29       Impact factor: 6.514

8.  PDR-1/hParkin negatively regulates the phagocytosis of apoptotic cell corpses in Caenorhabditis elegans.

Authors:  J Cabello; J Sämann; E Gómez-Orte; T Erazo; A Coppa; A Pujol; I Büssing; B Schulze; J M Lizcano; I Ferrer; R Baumeister; E Dalfo
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

9.  Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells.

Authors:  Gerard Ruiz-Babot; Mariya Balyura; Irene Hadjidemetriou; Sharon J Ajodha; David R Taylor; Lea Ghataore; Norman F Taylor; Undine Schubert; Christian G Ziegler; Helen L Storr; Maralyn R Druce; Evelien F Gevers; William M Drake; Umasuthan Srirangalingam; Gerard S Conway; Peter J King; Louise A Metherell; Stefan R Bornstein; Leonardo Guasti
Journal:  Cell Rep       Date:  2018-01-30       Impact factor: 9.423

10.  SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation.

Authors:  Tatiana Erazo; Sergio Espinosa-Gil; Nora Diéguez-Martínez; Néstor Gómez; Jose M Lizcano
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.